CELGENE CORPORATION : Study Evaluating REVLIMID® Combination ... 4-traders (press release) ... today announced data from a study comparing melphalan, prednisone and REVLIMID (lenalidomide) (MPR) with high-dose chemotherapy and tandem autologous stem cell transplant (MEL200), as well as evaluating the effect of lenalidomide maintenance ... |
